Terms: = Endocrine gland cancer AND RSPO2, Q6UXX9, 340419, ENSG00000147655, MGC43342, MGC35555 AND Treatment
3 results:
1. Identification of Clinical Relevant Molecular Subtypes of Pheochromocytoma.
Saddozai UAK; Wang F; Akbar MU; Zhang L; An Y; Zhu W; Xie L; Li Y; Ji X; Guo X
Front Endocrinol (Lausanne); 2021; 12():605797. PubMed ID: 34234737
[TBL] [Abstract] [Full Text] [Related]
2. T5224, rspo2 and AZD5363 are novel drugs against functional pituitary adenoma.
Zhong S; Wu B; Li J; Wang X; Jiang S; Hu F; Dou G; Zhang Y; Sheng C; Zhao G; Li Y; Chen Y
Aging (Albany NY); 2019 Oct; 11(20):9043-9059. PubMed ID: 31655798
[TBL] [Abstract] [Full Text] [Related]
3. Targeting the Wnt/β-catenin pathway in primary ovarian cancer with the porcupine inhibitor WNT974.
Boone JD; Arend RC; Johnston BE; Cooper SJ; Gilchrist SA; Oelschlager DK; Grizzle WE; McGwin G; Gangrade A; Straughn JM; Buchsbaum DJ
Lab Invest; 2016 Feb; 96(2):249-59. PubMed ID: 26658453
[TBL] [Abstract] [Full Text] [Related]
